Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Donna Rachel Vatnick"'
Autor:
Aviva Cohn, Donna Rachel Vatnick, Caroline Block, Justine A. Barletta, Ellen Marqusee, Judy Garber, Arezou A. Ghazani, Katelyn M. Breen, Meaghan Dwan, Samantha Stokes, Gerard M. Doherty, Huma Q. Rana
Publikováno v:
The American Journal of Case Reports
Patient: Female, 62-year-old Final Diagnosis: Medullary thyroid microcarcinoma Symptoms: No pain or swelling in her neck • no dysphagia or odynophagia • no changes in voice Medication: — Clinical Procedure: Genetic analysis Specialty: Genetics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8084d3e0061d9d03ea8e17a01f8dda2
https://doi.org/10.12659/ajcr.927415
https://doi.org/10.12659/ajcr.927415
Autor:
Fatemeh Fekrmandi, Tim Jaung, Alexi A. Wright, Judy Garber, Huma Q. Rana, Kristin Hehir, Ursula A. Matulonis, Angel M. Cronin, Samantha Stokes, Lindsay Kipnis, Donna Rachel Vatnick
Publikováno v:
Gynecologic oncology. 160(2)
Objective Germline genetic testing is crucial to the care of ovarian cancer patients, and as part of the guideline-based care for ovarian cancer patient's adherence to this recommendation has been low. We sought to determine whether embedding a genet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b730e8cc22b6c6858909b6f09c370e9
https://pubmed.ncbi.nlm.nih.gov/33229043
https://pubmed.ncbi.nlm.nih.gov/33229043
Autor:
Jill E. Stopfer, Lindsay Kipnis, Sara Pirzadeh-Miller, ProGen Study Team, Kevin D. Courtney, Samantha Culver, Diane R. Koeller, Jill S. Dolinsky, Donna Rachel Vatnick, Virginia Speare, Mary-Ellen Taplin, Judy Garber, Theodora S. Ross, Nancie Petrucelli, Huma Q. Rana, Rebecca Silver, Elisabeth I. Heath, Rebecca Gelman, Michelle Weitz, Brian Reys, Joanna Mercado
Publikováno v:
Journal of Clinical Oncology. 38:1507-1507
1507 Background: Approximately 10% of men with advanced prostate cancer (PC) have pathogenic/likely pathogenic variants (PV) in cancer susceptibility genes and their identification may lead to targeted therapy. Genetic testing (GT) can also guide can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00509a50841c13dd7b9ca3f0b87da911
https://doi.org/10.1200/jco.2020.38.15_suppl.1507
https://doi.org/10.1200/jco.2020.38.15_suppl.1507
Autor:
Samantha Culver, Christopher Sweeney, Jill E. Stopfer, Virginia Speare, Mark Pomerantz, Alexander E. Husband, Huma Q. Rana, Lindsay Kipnis, Sandjida Aktar, Judy Garber, Donna Rachel Vatnick, Kerry L. Kilbridge, Brigette Tippin Davis, Diane R. Koeller, Bradley Alexander McGregor, Kyle Allen, Jill S. Dolinsky, Mary-Ellen Taplin
Publikováno v:
Journal of Clinical Oncology. 37:TPS343-TPS343
TPS343 Background: Prostate cancer (PC) is among the leading causes of cancer mortality in males. Recent studies found 8-12% of advanced PC cases may be hereditary. Germline mutations have been reported in BRCA1/2, other DNA repair genes including AT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::297e3c5b7c6559ec5b2995b6de923866
https://doi.org/10.1200/jco.2019.37.7_suppl.tps343
https://doi.org/10.1200/jco.2019.37.7_suppl.tps343